报告摘要本周观点医药板块阶段震荡分化、轮动加快，建议把握主题轮动及底部调整机会，尤其是创新药产业链以及AI+板块。本周沪深300 指数下跌0.28%，医药生物下跌0.14%，处于31 个一级子行业第22 位。本周医药商业、医疗器械、医疗服务、中药分别上涨4.94%、1.16%、0.55%、0.17%；生物制品、化学制药分别下跌0.67%、1.74%。本周医药商业板块强势拉升。这与短期事件催化及长期...
Source Link报告摘要本周观点医药板块阶段震荡分化、轮动加快，建议把握主题轮动及底部调整机会，尤其是创新药产业链以及AI+板块。本周沪深300 指数下跌0.28%，医药生物下跌0.14%，处于31 个一级子行业第22 位。本周医药商业、医疗器械、医疗服务、中药分别上涨4.94%、1.16%、0.55%、0.17%；生物制品、化学制药分别下跌0.67%、1.74%。本周医药商业板块强势拉升。这与短期事件催化及长期...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.